Department of Experimental Immunology, Sanquin Research, Landsteiner Laboratory and Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Virology. 2010 Feb 5;397(1):224-30. doi: 10.1016/j.virol.2009.11.009. Epub 2009 Nov 27.
Autologous HIV-1-specific neutralizing antibodies (NAbs) seem unable to inhibit viral replication as they rapidly select for neutralization escape variants. However, NAbs could potentially contribute indirectly to the control of HIV-1 if changes in the viral envelope coinciding with NAb escape would impair viral replication fitness. Here we analyzed the replication kinetics of HIV-1 isolated over the course of infection from five typical progressors, three of whom developed strong autologous neutralizing humoral immunity. Viral replication rate did not correlate with viral sensitivity to autologous serum neutralization or with envelope length or number of potential N-linked glycosylation sites in gp120, suggesting that the flexibility of the viral envelope allows escape from NAbs without the loss of viral fitness. Interestingly, the appearance of rapidly replicating viruses late in infection correlated with lower CD4(+) T-cell counts, suggesting that this viral characteristic may be positively selected when the availability of target cells becomes limiting.
自体 HIV-1 特异性中和抗体 (NAb) 似乎无法抑制病毒复制,因为它们会迅速选择中和逃逸变异体。然而,如果与 NAb 逃逸同时发生的包膜变化会损害病毒复制适应性,那么 NAb 可能会间接地有助于 HIV-1 的控制。在这里,我们分析了从五个典型进展者的感染过程中分离出的 HIV-1 的复制动力学,其中三人产生了强烈的自体中和体液免疫。病毒复制率与自体血清中和敏感性、gp120 中包膜长度或潜在 N-连接糖基化位点的数量无关,这表明病毒包膜的灵活性允许 NAb 逃逸而不会丧失病毒适应性。有趣的是,感染后期快速复制病毒的出现与较低的 CD4(+)T 细胞计数相关,这表明当靶细胞的可用性变得有限时,这种病毒特征可能会被积极选择。